REGULATED CRYPTO EXCHANGE
Русский
Español
Theravance Biopharma, Inc.
Sell10.03
Spread0.08
Buy10.11

Trade Theravance Biopharma, Inc. - TBPH stock price

Sell10.03
Spread0.08
Buy10.11
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical trials for the treatment of rheumatoid arthritis, myelofibrosis, and ulcerative colitis, as well as for a range of inflammatory intestinal diseases, including ulcerative colitis and Crohn''s disease. In addition, the company''s product portfolio also comprise Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; TD-8236, an investigational, inhaled lung-selective pan-JAK inhibitor, which is Phase II clinical study for treatment of a range of inflammatory diseases; and TD-5202, an investigational, orally administered, gut-selective, irreversible JAK3 inhibitor that is in Phase I clinical study for treatment of inflammatory intestinal diseases. Further, it offers TRELEGY for the treatment of COPD; Velusetrag, an oral and investigational medicine for gastrointestinal motility disorders; and Selective 5-HT4 Agonist for treatment of gastrointestinal motility disorders. It has a licensing and collaboration agreements with Pfizer Inc., Viatris Inc., Janssen Biotech, Inc., Alfasigma S.p.A, and Takeda Pharmaceutical Company Limited. The company was incorporated in 2013 and is based in George Town, the Cayman Islands.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play Explore platform Show QR
Articles
BlackRock to launch Bitcoin ETF in Brazil
Read more
Spot Bitcoin ETFs record new trading volume ATHs in 2 straight days
Read more
SUN.io forges alliance with HTX DAO, promises surge in liquidity
Read more
Aptos surges 18%, development activity reaches 2-month high
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

TBPH price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 10.03 0.06 0.60 9.97 9.92 10.36
2022-09-30 10.2 0.03 0.29 10.17 10.05 10.41
2022-09-30 10.19 -0.41 -3.87 10.6 10.17 10.95
2022-09-30 10.02 0.04 0.40 9.98 9.72 10.12
2022-09-30 10.0 0.87 9.53 9.13 9.1 10.02
2022-09-30 9.35 0.23 2.52 9.12 9.03 9.37
2022-09-30 9.11 0.05 0.55 9.06 8.99 9.21
2022-09-30 9.23 0.15 1.65 9.08 9.03 9.25
2022-09-30 9.13 0.16 1.78 8.97 8.97 9.38
2022-09-30 9.32 0.00 0.00 9.32 9.23 9.54
2022-09-30 9.43 0.15 1.62 9.28 9.26 9.64
2022-09-30 9.39 0.19 2.07 9.2 9.2 9.52
2022-09-30 9.33 0.24 2.64 9.09 9.01 9.58
2022-09-30 9.35 0.66 7.59 8.69 8.69 9.36
2022-09-30 8.98 0.26 2.98 8.72 8.71 9.12
2022-09-30 8.96 -0.07 -0.78 9.03 8.83 9.14
2022-09-30 9.03 0.23 2.61 8.8 8.8 9.22
2022-09-30 9.0 -0.15 -1.64 9.15 8.92 9.29
2022-09-30 9.26 0.38 4.28 8.88 8.88 9.33
2022-09-30 9.03 0.00 0.00 9.03 8.87 9.18
Go help.dzengi.com